Vaccination shifted Indian healthcare system from reactive to proactive: Biotech Secy

6 December, 2022 | Vaishali Sharma

Children vaccine Health

India's healthcare ecosystem is in transition as it has shifted from being a reactive care system to proactive with the help of vaccination, said Rajesh Gokhale.

India’s healthcare ecosystem is in transition as it has shifted from being a reactive care system to proactive with the help of vaccination, said Rajesh Gokhale, Secretary at Department of Biotechnology, Government of India.

“Vaccination is an important component of proactive health where you actually take care of vaccinating yourself much before you get sick,” said Gokhale on Tuesday, adding that the government is working to develop various other curative therapies to strengthen the healthcare ecosystem in India. The Secretary made these remarks as part of his keynote address at a two-day International Meet on Preparedness for Future Epidemics “Is India ready to meet the CEPI 100 days vaccine challenge” held in Translational Health Science and Technology Institute (THSTI), Faridabad.

The meeting’s purpose is to create a plan for speeding vaccine idea, design, and delivery for any future pandemic.

Speaking remotely at the ceremony, the Secretary emphasised how Covid has demonstrated how science can prevail against all kind of foes in life.

“In fact, from the government’s point of view, I can just say that the Government of India is considering science and technology as one of the key attributes of the way the future of the 21st century will emerge for the Indian subcontinent.”

According to Gokhale, the Department of Biotechnology is proactively attempting to bring together, develop, and enhance the country’s bio-economy through manufacturing and research operations. He stated that in the current climate, technology solutions have become a “weapon” in terms of how governments prepare for any potential epidemic.

Furthermore, the Secretary stated that pandemic preparation is a difficult process and that it is critical for us to have scientific policies in place as well as the capability and competence to have an effect as and when necessary at an unprecedented pace.

“The DNA vaccine (which India developed) is the first of its kind in the country and wonderful work that was done and was published in Lancet as well. It really worth being proud of how trials and activities can be done in India at a scale that makes us all feel wonderfully happy about,” Gokhale added.